Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34301659.
- Also identified by DOI 10.1136/bmjopen-2020-048208 and PMC identifier 8311318.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
To provide lay information about genetics and sickle cell disease (SCD) and to identify and address ethical issues concerning the Sickle Cell Disease Genomics of Africa Network covering autonomy and research decision-making, risk of SCD complications and organ damage, returning of genomic findings, biorepository, data sharing, and healthcare provision for patients with SCD. Focus groups using qualitative methods. Six cities in Ghana, Nigeria and Tanzania within communities and secondary care. Patients, parents/caregivers, healthcare professionals, community leaders and government healthcare representatives. Results from 112 participants revealed similar sensitivities and aspirations around genomic research, an inclination towards autonomous decision-making for research, concerns about biobanking, anonymity in data sharing, and a preference for receiving individual genomic results. Furthermore, inadequate healthcare for patients with SCD was emphasised. Our findings revealed the eagerness of patients and parents/caregivers to participate in genomics research in Africa, with advice from community leaders and reassurance from health professionals and policy-makers, despite their apprehensions regarding healthcare systems.
Medical subject headings
- Anemia, Sickle Cell
- Biological Specimen Banks